Assembly Biosciences Inc (ASMB)
17.00
-0.05
(-0.29%)
USD |
NASDAQ |
Nov 15, 09:54
Assembly Biosciences Free Cash Flow (Quarterly): -17.12M for June 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -17.12M |
| March 31, 2024 | -18.38M |
| December 31, 2023 | 73.58M |
| September 30, 2023 | -13.98M |
| June 30, 2023 | -13.68M |
| March 31, 2023 | -23.43M |
| December 31, 2022 | -19.25M |
| September 30, 2022 | -19.92M |
| June 30, 2022 | -17.88M |
| March 31, 2022 | -27.50M |
| December 31, 2021 | -19.38M |
| September 30, 2021 | -18.88M |
| June 30, 2021 | -21.81M |
| March 31, 2021 | -36.42M |
| December 31, 2020 | -27.02M |
| September 30, 2020 | 10.65M |
| June 30, 2020 | -23.52M |
| March 31, 2020 | -25.28M |
| December 31, 2019 | -20.54M |
| September 30, 2019 | -18.60M |
| June 30, 2019 | -21.06M |
| March 31, 2019 | -25.43M |
| December 31, 2018 | -16.94M |
| September 30, 2018 | -16.72M |
| June 30, 2018 | -16.10M |
| Date | Value |
|---|---|
| March 31, 2018 | -15.54M |
| December 31, 2017 | -10.13M |
| September 30, 2017 | -11.46M |
| June 30, 2017 | -12.36M |
| March 31, 2017 | 34.94M |
| December 31, 2016 | -11.15M |
| September 30, 2016 | -7.897M |
| June 30, 2016 | -6.768M |
| March 31, 2016 | -9.213M |
| December 31, 2015 | -5.466M |
| September 30, 2015 | -5.186M |
| June 30, 2015 | -4.400M |
| March 31, 2015 | -3.704M |
| December 31, 2014 | -3.722M |
| September 30, 2014 | -3.893M |
| June 30, 2014 | -2.320M |
| March 31, 2014 | -5.188M |
| December 31, 2013 | -5.394M |
| September 30, 2013 | -4.655M |
| June 30, 2013 | -3.384M |
| March 31, 2013 | -4.370M |
| December 31, 2012 | -3.071M |
| September 30, 2012 | -5.284M |
| June 30, 2012 | -6.939M |
| March 31, 2012 | -6.090M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-36.42M
Minimum
Mar 2021
73.58M
Maximum
Dec 2023
-14.73M
Average
-19.38M
Median
Dec 2021
Free Cash Flow (Quarterly) Benchmarks
| ADMA Biologics Inc | 23.93M |
| Sensus Healthcare Inc | 4.227M |
| Protagonist Therapeutics Inc | -28.64M |
| Precision BioSciences Inc | -5.976M |
| Entrada Therapeutics Inc | -24.90M |